NEO Neogenomics PE ratio, current and historical analysis
The current price-to-earnings ratio of NEO can't be determined, as the TTM EPS of -$0.61 is negative. Neogenomics's last PE ratio on record was 114.86 in September 2021.
NEO PE ratio history
The mean historical PE ratio of Neogenomics over the last ten years is 683.72. In the past ten years, NEO's PE ratio reached its highest point in the Jun 2019 quarter at 2,194, with a price of $21.94 and an EPS of $0.01. The Jun 2021 quarter saw the lowest point at 74.05, with a price of $45.17 and an EPS of $0.61.
Neogenomics PE ratio by year
Maximum annual increase: 268.13% in 2020
| Year | PE ratio | Change |
|---|---|---|
| 2023 | N/A | N/A |
| 2022 | N/A | N/A |
| 2021 | N/A | N/A |
| 2020 | 1,346 | 268.13% |
| 2019 | 365.63 | 102.97% |
| 2018 | 180.14 | N/A |
| 2017 | N/A | N/A |
| 2016 | N/A | N/A |
| 2015 | N/A | N/A |
| 2014 | 208.5 | 130.39% |
NEO average PE ratio chart
NEO PE vs peers
| Stock name | PE ratio | Market cap |
|---|---|---|
| DGX Quest Diagnostics Inc | 20.36 | $17.09B |
| LH Laboratory Corp Of America Holdings | 43.05 | $19.12B |
| RDNT RadNet Inc | N/A | $5.38B |
| ENZ Enzo Biochem Inc | N/A | $39.85M |
| NEO Neogenomics Inc | N/A | $2.11B |
Frequently asked questions
What is Neogenomics's PE ratio?
The current price to earnings ratio of NEO can't be calculated, as its EPS of -$0.61 is negative.
What is the 5-year average PE ratio for Neogenomics (NEO)?
The 5-year average PE ratio for NEO stock is 564.17.
What is the highest PE ratio for NEO?
In the last ten years, the Jun 2019 quarter recorded the highest quarterly PE ratio at 2,194.
All PE ratio stats are based on quarterly TTM periods, unless otherwise specified. Data from 
and Sharadar.